The pulmonary hypertension academic research consortium

about

Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists

P2860

Q26860314-DE84462C-BAC4-4610-B11A-F29D83AC3650

P2860

The pulmonary hypertension academic research consortium

Item

http://www.wikidata.org/entity/Q36810808

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The pulmonary hypertension academic research consortium

@ast

The pulmonary hypertension academic research consortium

@en

type

Item

label

The pulmonary hypertension academic research consortium

@ast

The pulmonary hypertension academic research consortium

@en

prefLabel

The pulmonary hypertension academic research consortium

@ast

The pulmonary hypertension academic research consortium

@en

P1476

The pulmonary hypertension academic research consortium

@en

P2093

Stuart Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Ghost authorship in industry-initiated randomised trials

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

Childhood idiopathic pulmonary arterial hypertension: a national cohort study.

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

A model for dissemination and independent analysis of industry data.

Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

Optimizing trial design: sequential, adaptive, and enrichment strategies.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

P304

203-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2045-8932.109914

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236676276

http://www.w3.org/2001/XMLSchema#string

P698

23662198

http://www.w3.org/2001/XMLSchema#string

P932

3641731

http://www.w3.org/2001/XMLSchema#string

The pulmonary hypertension academic research consortium

about

P2860

P2860

The pulmonary hypertension academic research consortium

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932